Carrara-de Angelis Elisabete, Feher Olavo, Barros Ana Paula Brandao, Nishimoto Ines Nobuko, Kowalski Luiz Paulo
Department of Voice, Speech, and Swallowing Rehabilitation, Centro de Tratamento e Pesquisa Hospital do Câncer A. C. Camargo, São Paulo, Brazil.
Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):733-8. doi: 10.1001/archotol.129.7.733.
The main goals of larynx preservation protocols are preservation of a functional larynx with intact voice and maintenance of normal deglutition. However, few studies have addressed functional outcomes.
To evaluate voice and swallowing in patients enrolled in a larynx preservation protocol.
Acoustic analysis of 15 patients and videofluoroscopic evaluation of 14 patients who underwent chemoradiotherapy in an attempt to preserve the larynx.
Forty-three patients with larynx or hypopharynx squamous cell carcinomas were treated with weekly paclitaxel (30 mg/m2) and cisplatin (20 mg/m2) concurrent to radiotherapy (180-rad/d fraction [1.8 Gy] to 7040 rad [70.4 Gy]). Voice was analyzed perceptually and acoustically in 15 patients. Videofluoroscopic evaluation of swallowing was performed in 14 patients, focusing on oropharyngeal motility disorders, stasis, laryngeal penetration, aspiration, and dysphagia severity.
Vocal analysis produced normal results in 1 patient, mild dysphonia in 4, moderate dysphonia in 6, and severe dysphonia in 4. The mean fundamental frequency for acoustic analysis was 131.4 Hz for men and 109.8 Hz for women. Acoustic measures of perturbation and noise were above the reference limits, indicating changes in the voice signal. Swallowing analysis showed inefficient bolus preparation in 13 patients and changes in the bolus propulsion in 12. Stasis was observed in all areas of the oropharynx. Five patients had reduction in laryngeal elevation, and 12 had stasis in the hypopharynx. Five patients presented with silent aspiration. We detected functional swallowing in 3 patients, mild dysphagia in 7, mild or moderate dysphagia in 2, and severe dysphagia in 2.
Laryngeal preservation resulted in voice and swallowing abnormalities, but they tend to be mild to moderate, allowing intelligible communication and efficient swallowing in most patients.
喉保留方案的主要目标是保留具有完整发声功能的喉,并维持正常吞咽功能。然而,很少有研究涉及功能结局。
评估参与喉保留方案患者的发声和吞咽功能。
对15例患者进行声学分析,对14例接受放化疗以保留喉的患者进行电视荧光吞咽功能评估。
43例喉或下咽鳞状细胞癌患者接受每周一次的紫杉醇(30mg/m²)和顺铂(20mg/m²)同步放疗(每日分次剂量180拉德[1.8Gy],总量达7040拉德[70.4Gy])。对15例患者的发声进行了主观和声学分析。对14例患者进行了电视荧光吞咽功能评估,重点关注口咽运动障碍、食团停滞、喉穿透、误吸及吞咽困难的严重程度。
发声分析中,1例患者结果正常,4例为轻度发声障碍,6例为中度发声障碍,4例为重度发声障碍。声学分析中男性的平均基频为131.4Hz,女性为109.8Hz。微扰和噪声的声学指标高于参考限值,表明声音信号发生了变化。吞咽分析显示,13例患者食团准备效率低下,12例患者食团推进发生改变。口咽各区域均观察到食团停滞。5例患者喉抬高降低,12例患者下咽有食团停滞。5例患者存在隐性误吸。我们检测到3例患者吞咽功能正常,7例为轻度吞咽困难,2例为轻度或中度吞咽困难,2例为重度吞咽困难。
喉保留导致了发声和吞咽异常,但这些异常往往为轻至中度,多数患者仍可进行清晰的交流和有效的吞咽。